Governments strengthen health research in Manitoba
SUPPORT Unit builds foundation for patient-oriented research
SUPPORT Unit builds foundation for patient-oriented research
Cangene Corporation announced that its acquisition by Emergent BioSolutions Inc.has been completed.
LSAM recognizing industry successes.
Smith, founder and president of bressanté is a Certified Prosthetist and Clinical Anaplastologist and has been working for over three decades building an international reputation for excellence in the development of new techniques for creating highly deta
"This community does have a crippling deficiency in the availability of capital to get these great ideas off the lab table and on the way to the commercial marketplace."
Miraculins has made a deal with a Chinese company that could be worth $100 million or more for the distribution rights to sell its non-invasive diabetes screening test in China.
Pediatric hospital purchases Intelligent Hospital Systems’ most advanced RIVA system to increase safety and efficiency
Monsanto ranked 37th overall, and was 5th highest ranked among U.S. companies and 5th globally in the materials industry.
Investing in the biotechnology sector is an exercise in patience and not for the faint of heart
LSAM members working with these infectious agents should review the new Biosafety Directive for HIV and HTLV-1 for updated containment level requirements.
Mitacs applauds the Government of Canada for launching Canada’s International Education Strategy: Harnessing our knowledge advantage to drive innovation and prosperity.
Exports of the small black canola seeds and the cooking oil and animal feed they yield have more than doubled in the past 10 years.
Miraculins announced that it has filed pre-submission documentation with the USFDA for its Scout DS® System towards securing its ultimate marketing clearance in the US.
Kane entered into an option agreement with a Global Health Care Company who has been assessing some of Kane Biotech’s antibiofilm and antimicrobial technologies for use in the animal heath market.
Deal values Winnipeg biopharmaceutical company at $222M US.
Concierge Service to help SMEs access available government programs in one-stop shop
For the 2nd year in a row, St-Boniface Hospital Research has made the list of top research-intensive hospitals in Canada.
LSAM’S MEMBERS RISK THEIR LIVES TO ATTEND HOLIDAY PARTY
Winnipeg, Dec. 5 – Yesterday afternoon 50 of LSAM’s (Life Science Association of Manitoba) members braved…
A new online directory, launched by the Canada Foundation for Innovation, will help companies identify, locate and connect with research expertise and cutting-edge facilities across the country.
Pre-submission to FDA anticipated before calendar year-end
to determine pathway for U.S. marketing clearance
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.